Allergy Therapeutics results nothing to sneeze at
AIM-listed speciality pharmaceuticals company Allergy Therapeutics has reported a 10.6% increase in revenues for the six months ended 31st December.
6 years ago
Latest
DS Smith packages up its plastics division
International packaging firm DS Smith has announced the disposal of its plastics business to Olympus Partners for an enterprise value of…
6 years ago
Ultra Electronics sees lower profits but investors buy in
Shares in defence contractor Ultra Electronics shot 11.45% higher despite a 29.7% drop off in pre-tax profits for the year ended…
6 years ago
Mellon on the Markets: Arabian nights
Inside the mind of the Master Investor: British billionaire investor Jim Mellon reveals his latest thoughts on the markets.
6 years ago
Recovery in store for ITV and BAE Systems?
Robert Stephens, CFA, considers the turnaround potential of two underperforming FTSE 100 shares - defence giant BAE Systems and broadcaster…
6 years ago
Ibstock profits build during 2018
The share price of FTSE 250 brick and concrete manufacturer Ibstock rose by 4.14% after the firm posted a 19.1% improvement…
6 years ago
e-Therapeutics books loss but revenues are beginning to arrive
Drug discovery firm e-Therapeutics has seen its share price drop by 4.26% as it continued to make a loss during the…
6 years ago
Netcall shares up as profits surge
AIM-listed customer engagement specialist Netcall has said that pre-tax profits for the half year ended 31st December were up by 49%.
6 years ago
Where next for precious metals?
Gold and silver have been rising on the back of a weaker US dollar. Ex-IG chief market strategist David Jones…
6 years ago
Springfield Properties is cashing in on Scotland’s housing boom
Mark Watson-Mitchell has his eye on Springfield Properties, Scotland's only quoted housebuilder, which recently put out some very strong numbers.
6 years ago